EUCTR2013-000583-29-BE进行中（未招募）1 期
Corifollitropin alfa followed by hp-HMG versus recombinant FSH in young poor ovarian responders. A multicentre randomized controlled clinical trial - COMPORT
niversitair Ziekenhuis Brussel0 个研究点目标入组 150 人开始时间: 2013年3月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Patients participating in the COMPORT study will be women less than 40 years old who are considered poor ovarian responders according to the Bologna criteria (Ferrarretti et al. 2011).Eligible will be women <40 years old with at least 2 previous treatment cycles with = 3 oocytes retrieved after maximum stimulation for IVF/ICSI.In addition eligible will be women with at least 1 previous treatment cycle with = 3 oocytes retrieved and (antral follicle count <7 or antimullerian hormone levels <1.1ng/ml)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Uterine abnormalities;
- •Recent history of any current untreated endocrine abnormality;
- •Unilateral or bilateral hydrosalpinx (visible on USS, unless clipped);
- •Contraindications for the use of gonadotropins;
- •Recent history of severe disease requiring regular treatment
研究者
相似试验
招募中
3 期
evaluation the effect of Alnavar drug on patients with low ovarian reserve in ivf cyclediminished ovarian reserve in IVF cycle.Female infertility of other originN97.8IRCT20221016056198N1Shahid Beheshti University of Medical Sciences90
进行中（未招募）
1 期
Optimisation of follicular recruitment in IVM cyclesInfertile patients with polycystic ovariesMedDRA version: 20.0Level: LLTClassification code 10065161Term: Polycystic ovarian syndromeSystem Organ Class: 100000019245EUCTR2017-002571-25-BEZ Brussel145
已完成
3 期
A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)HypogonadismHypogonadotropic HypogonadismNCT01709331Organon and Co18
进行中（未招募）
1 期
sefulness of Corifollitropin alfa as alternative to conventional daily rFSH protocols in oocyte donors undergoing pituitary suppression with Medroxiprogesterona acetate (MPA).CTIS2023-506908-66-00Ivi Valencia S.L.318
已完成
3 期
Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders TrialPoor Ovarian ResponseInfertilityNCT01816321Universitair Ziekenhuis Brussel150